Literature DB >> 11294784

Melatonin or a melatonin agonist corrects age-related changes in circadian response to environmental stimulus.

O Van Reeth1, L Weibel, E Olivares, S Maccari, E Mocaer, F W Turek.   

Abstract

The effects of a melatonin agonist, S-20098, included in the diet were tested on a specific effect of aging in hamsters: the marked decline in the phase shifting effects of a 6-h pulse of darkness on a background of constant light. In contrast to young hamsters, old hamsters fed with the control diet showed little or no phase shifts in response to a dark pulse presented in the middle of their inactive or active period. Old hamsters fed with S-20098 showed phase shifts that were ~70% of the ones in young animals and significantly greater than those in old controls. The phase advancing response to a dark pulse presented during the inactive period was dose dependent and reversed after S-20098 discontinuation. Melatonin included in the diet showed comparable restorative effects on the phase shifting response to a dark pulse in old hamsters. Replacement therapy with melatonin or melatonin-related compounds could prove useful in treating, preventing, or delaying disturbances of circadian rhythmicity and/or sleep in older people.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11294784     DOI: 10.1152/ajpregu.2001.280.5.R1582

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  18 in total

1.  How to fix a broken clock.

Authors:  Analyne M Schroeder; Christopher S Colwell
Journal:  Trends Pharmacol Sci       Date:  2013-10-10       Impact factor: 14.819

Review 2.  Circadian rhythm disturbances in depression.

Authors:  Anne Germain; David J Kupfer
Journal:  Hum Psychopharmacol       Date:  2008-10       Impact factor: 1.672

3.  Agomelatine: protecting the CNS from the effects of stress.

Authors:  Stefania Maccari; Ferdinando Nicoletti
Journal:  CNS Neurosci Ther       Date:  2011-10       Impact factor: 5.243

Review 4.  Agomelatine, the first melatonergic antidepressant: discovery, characterization and development.

Authors:  Christian de Bodinat; Béatrice Guardiola-Lemaitre; Elisabeth Mocaër; Pierre Renard; Carmen Muñoz; Mark J Millan
Journal:  Nat Rev Drug Discov       Date:  2010-06-25       Impact factor: 84.694

5.  Activation of Melatonin Receptors Reduces Relapse-Like Alcohol Consumption.

Authors:  Valentina Vengeliene; Hamid R Noori; Rainer Spanagel
Journal:  Neuropsychopharmacology       Date:  2015-05-21       Impact factor: 7.853

6.  The timing of the shrew: continuous melatonin treatment maintains youthful rhythmic activity in aging Crocidura russula.

Authors:  Elodie Magnanou; Joël Attia; Roger Fons; Gilles Boeuf; Jack Falcon
Journal:  PLoS One       Date:  2009-06-15       Impact factor: 3.240

7.  Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.

Authors:  Michel Bourin; Elisabeth Mocaër; Roger Porsolt
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186

Review 8.  Agomelatine: innovative pharmacological approach in depression.

Authors:  Maurizio Popoli
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

9.  Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade.

Authors:  Mark J Millan; Mauricette Brocco; Alain Gobert; Anne Dekeyne
Journal:  Psychopharmacology (Berl)       Date:  2004-07-31       Impact factor: 4.530

10.  Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats.

Authors:  Abdeslam Chagraoui; Philippe Protais; Thierry Filloux; Elisabeth Mocaër
Journal:  Psychopharmacology (Berl)       Date:  2003-08-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.